Valeant Pharmaceuticals is nearing a deal to buy Salix Pharmaceuticals for about $10 billion, in the latest sign the rapid pace of consolidation in the drug industry is set to continue.
via WSJ.com: US Business http://ift.tt/17G10km
via WSJ.com: US Business http://ift.tt/17G10km
Nessun commento:
Posta un commento